Cargando…
Valsartan impedes epinephrine-induced ICAM-4 activation on normal, sickle cell trait and sickle cell disease red blood cells
Abnormal red blood cell (RBC) adhesion to endothelial αvβ3 plays a crucial role in triggering vaso-occlusive episodes in sickle cell disease (SCD). It is known that epinephrine, a β-adrenergic receptor (β-AR) stimulator, increases the RBC surface density of active intercellular adhesion molecule-4 (...
Autores principales: | Zhang, Jing, Jones, Sasia-Marie, Lykotrafitis, George, Andemariam, Biree |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513067/ https://www.ncbi.nlm.nih.gov/pubmed/31083675 http://dx.doi.org/10.1371/journal.pone.0216467 |
Ejemplares similares
-
Patient Controlled Analgesia for Adults with Sickle Cell Disease Awaiting Admission from the Emergency Department
por: Santos, Josue, et al.
Publicado: (2016) -
Elastic property of sickle cell anemia and sickle cell trait red blood cells
por: Muhammed, Endris, et al.
Publicado: (2021) -
Serious adverse events in African–American cancer patients with sickle cell trait and inherited haemoglobinopathies in a SEER-Medicare claims cohort
por: Hoag, Jessica R., et al.
Publicado: (2019) -
Annual Academy of Sickle Cell and Thalassaemia (ASCAT) conference: a summary of the proceedings
por: Strunk, Crawford, et al.
Publicado: (2020) -
Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)